When testing testosterone replacement therapy, the initial response should not be evaluated as a double-blind placebo-controlled trial because placebo effects will be present, so instead clinicians should look for a "hell yes" response, and if the response is equivocal, the treatment should be discontinued and symptoms reassessed to determine if the deficit reappears.
normativepending
Speaker
Unidentified Speaker — Peter Attia on Treating Low Testosterone (and why TRT isn't… [htfbGGeliZU]Evidence Quote
“if the response we see isn't a hell yes I think we should pull pull it all off and see if we notice a response in the deficit”
Source
Peter Attia on Treating Low Testosterone (and why TRT isn't always the right answer)— FoundMyFitness ClipsCreated: 8/12/2026, 6:01:12 PM
Your notes
Loading notes...